The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...
New technologies emerging from the Human Genome Project and the rapidly expanding direct-to-consumer DNA testing have provided a challenging environment for the entry of pharmacogenomics into clinical ...
ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is highlighting a peer-reviewed study that independently ...
Those who say we practice 19th Century medicine in the 21st Century usually are referring to paper medical records, but could just as well be speaking about pathology, since laboratory medicine has ...
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...
The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...
The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback